Literature DB >> 6425288

Purification and properties of thiol beta-lactamase. A mutant of pBR322 beta-lactamase in which the active site serine has been replaced with cysteine.

I S Sigal, W F DeGrado, B J Thomas, S R Petteway.   

Abstract

The specifically mutated enzyme thiol beta-lactamase has been expressed in Escherichia coli by means of the trp promoter and purified to homogeneity. The gene for this enzyme results from a single base change N410 A----T in the gene of pBR322 RTEM beta-lactamase (EC 3.5.2.6, penicillinase, penicillin amido-beta-lactamhydrolase) which alters the codon for the active site Ser 70 to that for Cys. Precursor thiol beta-lactamase is processed to give the same NH2-terminal sequence as that for wild type enzyme. In contrast to the wild type enzyme, thiol beta-lactamase contains one free titratable thiol group/molecule. Thiol beta-lactamase catalyzes the hydrolysis of beta-lactams with a substrate specificity that is distinct from that of wild type enzyme. For benzyl-penicillin and ampicillin, the Km values are similar to wild type values although the kcat values are 1-2% that of wild type enzyme. For the cephalosporin nitrocefin, the Km is greater than 10-fold that of the wild type and the kcat is at least as large as the kcat for the wild type enzyme. Thiol beta-lactamase is different from wild type beta-lactamase in that it is not competitively inhibited by boric acid although a small degree of noncompetitive inhibition does occur. Whereas the circular dichroism spectra of both enzymes are nearly identical, thiol beta-lactamase at 40 degrees C is 3-fold more resistant to trypsin than is the wild type enzyme.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6425288

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Protein splicing removes intervening sequences in an archaea DNA polymerase.

Authors:  R A Hodges; F B Perler; C J Noren; W E Jack
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

2.  Inactivation of the thiol RTEM-1 beta-lactamase by 6-beta-bromopenicillanic acid. Identity of the primary active-site nucleophile.

Authors:  A K Knap; R F Pratt
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

3.  Active-site serine mutants of the Streptomyces albus G beta-lactamase.

Authors:  F Jacob; B Joris; J M Frère
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

4.  Leakage of periplasmic enzymes from envA1 strains of Escherichia coli.

Authors:  K Young; L L Silver
Journal:  J Bacteriol       Date:  1991-06       Impact factor: 3.490

5.  The diversity of the catalytic properties of class A beta-lactamases.

Authors:  A Matagne; A M Misselyn-Bauduin; B Joris; T Erpicum; B Granier; J M Frère
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

6.  Beta-lactamases as fully efficient enzymes. Determination of all the rate constants in the acyl-enzyme mechanism.

Authors:  H Christensen; M T Martin; S G Waley
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

7.  Trapping the acyl-enzyme intermediate in beta-lactamase I catalysis.

Authors:  S J Cartwright; A K Tan; A L Fink
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

8.  Protein switches identified from diverse insertion libraries created using S1 nuclease digestion of supercoiled-form plasmid DNA.

Authors:  Jennifer Tullman; Gurkan Guntas; Matthew Dumont; Marc Ostermeier
Journal:  Biotechnol Bioeng       Date:  2011-06-15       Impact factor: 4.530

9.  Extension of the substrate spectrum by an amino acid substitution at residue 219 in the Citrobacter freundii cephalosporinase.

Authors:  K Tsukamoto; R Ohno; T Sawai
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

10.  Folding and aggregation of TEM beta-lactamase: analogies with the formation of inclusion bodies in Escherichia coli.

Authors:  G Georgiou; P Valax; M Ostermeier; P M Horowitz
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.